✦ LIBER ✦

HGT-REP-059 treatment protocol: effect and tolerability of open-label agalsidase alfa in patients with Fabry disease

✍ Scribed by Goker-Alpan, Ozlem; Nedd, Khan; Shankar, Suma; Lien, Y. Howard; Weinreb, Neal; Wijatyk, Anna; Chang, Peter; Martin, Rick

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and effect of open-label agalsida

✍ Pano, Arian; Goker-Alpan, Ozlem; Longo, Nicola; McDonald, Marie; Shankar, Suma; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

An open-label, switchover trial to asses

✍ Richards, Sarah; Laney, Dawn; Pervaiz, Muhammad A.; Shankar, Suma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Safety and Efficacy of Enzyme Replacemen

✍ J. Edmond Wraith; Anna Tylki-Szymanska; Nathalie Guffon; Y. Howard Lien; Michel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

[JIMD Reports] JIMD Reports - Case and R

✍ Zschocke, Johannes; Gibson, K Michael; Brown, Garry; Morava, Eva; Peters, Verena 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg ⚖ 163 KB

A randomized, multicenter, multinational

✍ Wijburg, Frits; Bénichou, Bernard; Bichet, Daniel G.; Dostalova, Gabriela; Clark 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB

A 6-month open-label study of the effect

✍ C.E. Patterson; A.P. Passmore; V.L.S. Crawford 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB